Product Information
TAFLUPROST 0.0015% EYE DROP is a generic product labeled by Micro Labs Limited, priced at $2.5020 per EA under NDC 42571026473. Its NADAC has been published 175 times since Feb 22, 2023.
Strength
.0045 mg/.3mL
Manufacturer
Micro Labs LimitedNDC
42571026473
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
TAFLUPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA209051On Market Since
11/18/2022
Pharmacological Classes
Price Statistics
The NADAC for TAFLUPROST 0.0015% EYE DROP has been published 175 times since Feb 22, 2023, and over the history we have for it it has declined 41.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5020 per EA |
|---|---|
| All-time high | $4.7773 (May 10, 2023) |
| All-time low | $2.5020 (Jun 17, 2026) |
| 52-week high | $3.3303 |
| 52-week low | $2.5020 |
| Median price | $3.5088 |
| Average price | $3.5566 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 175 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the tafluprost opthalmic market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TAFLUPROST 0.0015% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TAFLUPROST 0.0015% EYE DROP, manufactured by Micro Labs Limited, is $2.5020 per EA (NDC 42571026473), effective Jun 24, 2026.
How has the price of TAFLUPROST 0.0015% EYE DROP changed over time?
Over the history we have for it, the NADAC for TAFLUPROST 0.0015% EYE DROP has declined 41.7%. It has been tracked across 175 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for TAFLUPROST 0.0015% EYE DROP?
Since Feb 22, 2023, the NADAC for TAFLUPROST 0.0015% EYE DROP has ranged from a low of $2.5020 (Jun 17, 2026) to a high of $4.7773 (May 10, 2023), with a median of $3.5088 per EA.
Are there cheaper alternatives to TAFLUPROST 0.0015% EYE DROP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TAFLUPROST 0.0015% EYE DROP, so no direct lower-cost alternative is listed.
Who manufactures TAFLUPROST 0.0015% EYE DROP?
TAFLUPROST 0.0015% EYE DROP (NDC 42571026473) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification